Matches in SemOpenAlex for { <https://semopenalex.org/work/W3017224854> ?p ?o ?g. }
- W3017224854 endingPage "1563" @default.
- W3017224854 startingPage "1554" @default.
- W3017224854 abstract "Infliximab (IFX), as a drug of first-line therapy, can alter the natural progression of Crohn's disease (CD), promote mucosal healing and reduce complications, hospitalizations, and the incidence of surgery. Perianal fistulas are responsible for the refractoriness of CD and represent a more aggressive disease. IFX has been demonstrated as the most effective drug for the treatment of perianal fistulizing CD. Unfortunately, a significant proportion of patients only partially respond to IFX, and optimization of the therapeutic strategy may increase clinical remission. There is a significant association between serum drug concentrations and the rates of fistula healing. Higher IFX levels during induction are associated with a complete fistula response in these patients. Given the apparent relapse of perianal fistulizing CD, maintenance therapy with IFX over a longer period seems to be more beneficial. It appears that patients without deep remission are at an increased risk of relapse after stopping anti-tumor necrosis factor agents. Thus, only patients in prolonged clinical remission should be considered for withdrawal of IFX treatment when biomarker and endoscopic remission is demonstrated, especially when the hyperintense signals of fistulas on T2-weighed images have disappeared on magnetic resonance imaging. Fundamentally, the optimal timing of IFX use is highly individualized and should be determined by a multidisciplinary team." @default.
- W3017224854 created "2020-04-24" @default.
- W3017224854 creator A5000513199 @default.
- W3017224854 creator A5015894671 @default.
- W3017224854 creator A5016585741 @default.
- W3017224854 creator A5027655104 @default.
- W3017224854 creator A5032105141 @default.
- W3017224854 creator A5066599544 @default.
- W3017224854 date "2020-04-14" @default.
- W3017224854 modified "2023-10-14" @default.
- W3017224854 title "Optimized timing of using infliximab in perianal fistulizing Crohn's disease" @default.
- W3017224854 cites W1573665883 @default.
- W3017224854 cites W1941774409 @default.
- W3017224854 cites W1974202307 @default.
- W3017224854 cites W1975818959 @default.
- W3017224854 cites W1976961853 @default.
- W3017224854 cites W1987408542 @default.
- W3017224854 cites W1990943062 @default.
- W3017224854 cites W1998063704 @default.
- W3017224854 cites W2025031929 @default.
- W3017224854 cites W2026116536 @default.
- W3017224854 cites W2031330050 @default.
- W3017224854 cites W2039648562 @default.
- W3017224854 cites W2047158379 @default.
- W3017224854 cites W2056917411 @default.
- W3017224854 cites W2069644264 @default.
- W3017224854 cites W2086501095 @default.
- W3017224854 cites W2087663450 @default.
- W3017224854 cites W2088160887 @default.
- W3017224854 cites W2091385020 @default.
- W3017224854 cites W2105311242 @default.
- W3017224854 cites W2108825621 @default.
- W3017224854 cites W2118017902 @default.
- W3017224854 cites W2118497620 @default.
- W3017224854 cites W2126807394 @default.
- W3017224854 cites W2128406046 @default.
- W3017224854 cites W2159143303 @default.
- W3017224854 cites W2322130077 @default.
- W3017224854 cites W2326330820 @default.
- W3017224854 cites W2327595099 @default.
- W3017224854 cites W2331924809 @default.
- W3017224854 cites W2342621071 @default.
- W3017224854 cites W2410520654 @default.
- W3017224854 cites W2427633307 @default.
- W3017224854 cites W2443902526 @default.
- W3017224854 cites W2517278722 @default.
- W3017224854 cites W2523659127 @default.
- W3017224854 cites W2528535517 @default.
- W3017224854 cites W2555824909 @default.
- W3017224854 cites W2587787178 @default.
- W3017224854 cites W2589591052 @default.
- W3017224854 cites W2598305470 @default.
- W3017224854 cites W2607150294 @default.
- W3017224854 cites W2708784500 @default.
- W3017224854 cites W2740303420 @default.
- W3017224854 cites W2742311423 @default.
- W3017224854 cites W2744879509 @default.
- W3017224854 cites W2757742334 @default.
- W3017224854 cites W2764220681 @default.
- W3017224854 cites W2791720823 @default.
- W3017224854 cites W2793442523 @default.
- W3017224854 cites W2794388065 @default.
- W3017224854 cites W2797152839 @default.
- W3017224854 cites W2800612704 @default.
- W3017224854 cites W2823127786 @default.
- W3017224854 cites W2889627806 @default.
- W3017224854 cites W2890258621 @default.
- W3017224854 cites W2892542460 @default.
- W3017224854 cites W2906229755 @default.
- W3017224854 cites W2906604043 @default.
- W3017224854 cites W2915154296 @default.
- W3017224854 cites W2916794721 @default.
- W3017224854 cites W2922984825 @default.
- W3017224854 cites W2924681713 @default.
- W3017224854 cites W2950457069 @default.
- W3017224854 cites W2975763330 @default.
- W3017224854 cites W4299530009 @default.
- W3017224854 doi "https://doi.org/10.3748/wjg.v26.i14.1554" @default.
- W3017224854 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7167413" @default.
- W3017224854 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32327905" @default.
- W3017224854 hasPublicationYear "2020" @default.
- W3017224854 type Work @default.
- W3017224854 sameAs 3017224854 @default.
- W3017224854 citedByCount "6" @default.
- W3017224854 countsByYear W30172248542020 @default.
- W3017224854 countsByYear W30172248542021 @default.
- W3017224854 countsByYear W30172248542022 @default.
- W3017224854 countsByYear W30172248542023 @default.
- W3017224854 crossrefType "journal-article" @default.
- W3017224854 hasAuthorship W3017224854A5000513199 @default.
- W3017224854 hasAuthorship W3017224854A5015894671 @default.
- W3017224854 hasAuthorship W3017224854A5016585741 @default.
- W3017224854 hasAuthorship W3017224854A5027655104 @default.
- W3017224854 hasAuthorship W3017224854A5032105141 @default.
- W3017224854 hasAuthorship W3017224854A5066599544 @default.
- W3017224854 hasBestOaLocation W30172248541 @default.
- W3017224854 hasConcept C126322002 @default.
- W3017224854 hasConcept C2777138892 @default.